AC2
A Randomized Controlled Trial Comparing Avatar Intervention to an Addiction Supportive Intervention to Reduce Cannabis Use in Patients With Psychotic Disorders
Sponsor study identifier
interventional
150
1 country
1
Study Start
February 1, 2023
Actual (reported)Primary Completion
January 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
January 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
The goal of this clinical trial is to conduct a single-blind randomized controlled trial to verify whether the Avatar Intervention has greater efficacy over supportive intervention to reduce cannabis use in patients with psychotic disorders.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 20, 2023
Actual (reported)January 30, 2023
Actual (reported)February 1, 2023
Actual (reported)January 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
January 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Change in cannabis use (Timeline Follow-Back)
A standardized tool consisting of asking the patients how many joints they smoked each day of the week during the past week.
Within 1 week before treatment, within 1 week after treatment, follow-ups at 3 months, 6 months and 12 months
Change in the severity of the cannabis use disorder (Cannabis Use Problems Identification Test - CUPIT)
Within 1 week before treatment, within 1 week after treatment, follow-ups at 3 months, 6 months and 12 months
Change in quality of life(Quality of Life Enjoyment and Satisfaction Questionnaire - QLESQ-SF & Quality of Life Scale - QLS)
Within 1 week before treatment, within 1 week after treatment, follow-ups at 3 months, 6 months and 12 months
The Avatar Intervention will take place over 8 consecutive weeks, with one session per week. Additional sessions (up to a maximum of 4 sessions) will be offered if needed. Each session will last approximately 60 minutes. The goal of the intervention will be to help you reduce cravings related to your cannabis use with the use of virtual reality and avatars.
The Addiction supportive intervention will take place over 8 consecutive weeks, with one session per week. Additional sessions (up to a maximum of 4 sessions) will be offered if needed. Each session will last approximately 60 minutes. The goal of the intervention will be to help you reduce cravings related to your cannabis use.
8 weekly sessions of 60 minutes. Possibility of 4 additional sessions.
8 weekly sessions of 60 minutes. Possibility of 4 additional sessions.
Research center of the Institut universitaire en santé mentale de Montréal
Montreal, Quebec, H1N 3M5, Canada
Alexandre Dumais, MD, PhD
University of Montreal, Institut universitaire en santé mentale de Montréal
Stephane Potvin, PhD
University of Montreal, Institut universitaire en santé mentale de Montréal
Emmanuel Stip, MD, MSc
United Arab Emirates University
Amal Abdel Baki, MD, MSc
University of Montreal, Centre hospitalier de l'Université de Montréal
First Submitted
January 20, 2023
First Posted
January 30, 2023
Study Start
February 1, 2023
Actual (reported)Primary Completion
January 2027
Regulated Cannabis Access in Basel
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Robert-Paul Juster, PhD
University of Montreal, Institut universitaire en santé mentale de Montréal
Marie-Hélène Goulet, PhD
University of Montreal, Institut universitaire en santé mentale de Montréal
Luigi De Benedictis, MD
Institut universitaire en santé mentale de Montréal
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
January 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
February 7, 2024
Record last verified: 2024-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: